UnknownPhase 4NCT00393614
Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)
Studying Developmental and epileptic encephalopathy with spike-wave activation in sleep
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oslo University Hospital
- Principal Investigator
- Ann-Sofie Eriksson, MD PhdOslo University Hospital
- Intervention
- levetiracetam(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 5-10 years · All sexes
- Timeline
- 2007 – 2010
Study locations (1)
- Rikshospitalet-Radiumhospitalet HF, Oslo, Norway
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00393614 on ClinicalTrials.govOther trials for Developmental and epileptic encephalopathy with spike-wave activation in sleep
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT04034030Repeated Oscillatory TMS Therapy of the Epileptogenic Cortical Area in Children With Focal CSWSChildren's Mercy Hospital Kansas City
- RECRUITINGNANCT03865771Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy.University Hospital, Strasbourg, France
See all trials for Developmental and epileptic encephalopathy with spike-wave activation in sleep →